Biopharma

3 posts

Pharmaceutical Distribution Systems – A Strategic Opportunity – Asrar Qureshi’s Blog Post #1215

Asrar Qureshi’s blog post discusses the urgent need for modernizing pharmaceutical distribution in Pakistan, shifting from a traditional logistics model to a strategic healthcare framework. It emphasizes cold-chain capabilities and digital transformation to improve patient outcomes as the market evolves towards specialty medicines and biologics, urging collaboration among stakeholders.
Share
View Post
  • 6 min

Kiran Mazumdar-Shaw’s Bold Healthcare Mission – Asrar Qureshi’s Blog Post #1203

Asrar Qureshi’s blog post highlights Kiran Mazumdar-Shaw’s transformative journey with Biocon, emphasizing her mission-driven leadership in biotechnology. She advocates for affordable, accessible healthcare and resilient innovation, turning challenges into opportunities. Mazumdar-Shaw’s insights stress the importance of purpose, collaboration, and ecosystem development in creating impactful healthcare solutions for emerging markets.
Share
View Post
  • 5 min

New Drug Modalities – Asrar Qureshi’s Blog Post 1047

Asrar Qureshi’s blog discusses the Boston Consulting Group’s second annual report on the growth of new drug modalities. It highlights advancements in antibodies, recombinant products, cell therapies, gene therapies, and mRNA applications, emphasizing their implications for biopharma companies and patient care. The future of these modalities depends on their unique benefits and market speed.
Share